David A. Siegel Vascular Biogenics Ltd. Transaction History

Two Sigma Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.21 - $0.32 $3,150 - $4,800	15,000 New	15,000 $3,000
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.16 $1,474 - $2,144	-13,400 Reduced 15.35%	73,900 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.15 - $2.1 $13,095 - $183,330	87,300 New	87,300 $14,000
Q4 2021 Feb 14, 2022	SELL	$1.92 - $2.53 $27,648 - $36,432	-14,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.94 - $2.55 $27,936 - $36,720	14,400 New	14,400 $30,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.